I think proving up 1P and doubling up 2P resources would be the short-term objective. That's probably why they are focusing on testing KF at the moment.
Finding development JV partners or selling assets would be their medium to long term view. MEL is way undervalue based on reserves in comparison to peers like Eastern Star, Molopo and Bow.
- Forums
- ASX - By Stock
- takeover invitation
MEL
metgasco ltd
Add to My Watchlist
0.00%
!
0.3¢

I think proving up 1P and doubling up 2P resources would be the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.581M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 17506809 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 10711228 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 17506809 | 0.002 |
10 | 38800998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 10711228 | 11 |
0.004 | 10479052 | 6 |
0.006 | 311675 | 1 |
0.020 | 15085 | 1 |
0.022 | 91666 | 1 |
Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
Featured News
MEL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online